Early Insulin Therapy in Very Low Birth Weight Infants
Author Information
Author(s): Beardsall Kathryn, Vanhaesebrouck Sophie, Ogilvy-Stuart Amanda L, Ahluwalia Jag S, Vanhole Christine, Palmer Christopher, Midgley Paula, Thompson Mike, Cornette Luc, Weissenbruch Mirjam, Thio Marta, de Zegher Francis, Dunger David
Primary Institution: Department of Paediatrics, University of Cambridge
Hypothesis
We propose that relative insulin deficiency in the very low birth weight baby leads to catabolism, insulin resistance and hyperglycaemia during the first week of life.
Conclusion
Early continuous insulin infusion may prevent catabolism and improve glucose control in very low birth weight infants.
Supporting Evidence
- Insulin therapy in adults has shown improved outcomes in critical care settings.
- Hyperglycaemia in premature neonates is associated with increased morbidity and mortality.
- Early insulin infusion may improve glucose control and reduce the risk of sepsis.
Takeaway
This study is about giving insulin to tiny babies right after they are born to help them grow better and stay healthy.
Methodology
A multi-centre, randomised controlled trial comparing continuous insulin infusion with standard neonatal care.
Potential Biases
Potential bias in recruitment and consent processes.
Limitations
The study may not account for all variables affecting outcomes in very low birth weight infants.
Participant Demographics
Very low birth weight infants (birth weight < 1500 g) requiring intensive care.
Statistical Information
P-Value
p<0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website